Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency

Pediatr Nephrol. 2016 Jan;31(1):83-8. doi: 10.1007/s00467-015-3195-2. Epub 2015 Sep 4.

Abstract

Background: Oxidative stress has been reported to play an important role in children with primary nephrotic syndrome (PNS). However, the results of previous studies are controversial.

Methods: Forty children with steroid-sensitive nephrotic syndrome (SSNS) and 20 age- and sex-matched healthy controls were enrolled. Patients were followed-up for 12-18 months and divided into three subgroups: frequent relapse (n = 10), non-frequent relapse (n = 12), and non-relapse (n = 18). The plasma levels of advanced oxidation protein products (AOPP), malondialdehyde (MDA), and superoxide dismutase (SOD) were tested in controls and patient group at first presentation and after 4 weeks of steroid treatment.

Results: Patients had higher AOPP and MDA levels but lower SOD compared with controls. AOPP levels were significantly higher in the frequent relapse subgroup compared with the non-frequent relapse and non-relapse subgroups, respectively. No significant differences were found in the plasma levels of MDA and SOD among the three subgroups. AOPP >87.55 μmol/l before steroid treatment and AOPP >78.5 μmol/l after 4-week steroid treatment were positively correlated with the relapse frequency in patients with SSNS.

Conclusions: Children with SSNS have oxidative stress. The plasma levels of AOPP before and after 4-week steroid treatment may predict whether patients with SSNS will relapse frequently.

Keywords: Children; Oxidative stress; Relapse; Steroid-sensitive nephrotic syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Advanced Oxidation Protein Products / blood*
  • Biomarkers / blood
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Malondialdehyde / blood
  • Nephrotic Syndrome / blood*
  • Nephrotic Syndrome / diagnosis
  • Nephrotic Syndrome / drug therapy*
  • Oxidative Stress / drug effects*
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Risk Factors
  • Steroids / therapeutic use*
  • Superoxide Dismutase / blood
  • Time Factors
  • Treatment Outcome

Substances

  • Advanced Oxidation Protein Products
  • Biomarkers
  • Steroids
  • Malondialdehyde
  • Superoxide Dismutase